| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.22 | 0.2 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.2 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.2 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |